Midas Pharma Polskasp. z o.o.
Agents specialised in the sale of other particular products
Overview
Midas Pharma Polska is a company that provides a wide range of products and services across the pharmaceutical value chain, including starting materials, chemicals, drug substances, and drug products. They also offer contract development, contract manufacturing, and supply chain management services. Additionally, Midas Pharma specializes in medical devices and platform technologies such as hot melt extrusion.
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2005-09-01. Active
40 1880 0009 0000 0011 0150 2000- 13 1880 0009 0000 0011 0150 2001
- 29 1880 0009 0000 0011 0150 2004
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 2, 2017 | Return of additional payments |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the company has a multi-member management board, two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, are authorised to make declarations concerning the company's property rights and obligations and to sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
K.h.s. Pharma Holding Gmbh | 999 | $13,492.71 | 99.9% |
Others | 1 | $13.51 | 0.1% |
Beneficial owners
| Person | Rights |
|---|---|
Alexandra Rittgen (53)  | Posiadanie ponad 25% udziałów w spółkach zoo będących właścicielem 100% udziałów zgłaszanej spółki zoo |
Christian Martin Schleicher (50) | Posiadanie ponad 25% udziałów w spółkach zoo będących właścicielem 100% udziałów zgłaszanej spółki zoo |
Karl Heinz Otto Schleicher (82) | Posiadanie ponad 25% udziałów w spółkach zoo będących właścicielem 100% udziałów zgłaszanej spółki zoo |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| SymbaseS.A. | $26,081,930.68 | cfiworld.pl | |
| Shim-Pol A.M.Borzymowski E.Borzymowska-Reszka, A.Reszkasp. j. | $26,039,075.33 | shim-pol.pl | |
| SNF Polskasp. z o.o. | $24,555,575.97 | koronajv.pl | |
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | |
| Biochem PolskaS.A. | $13,180,007.81 | biochempolska.pl | |
| PolypharmS.A. | $13,084,716.73 | polypharm.pl | |
| PromedS.A. | $12,643,674.56 | promed.com.pl | |
| Nova Group A. Chmielewskisp. k. | $12,556,899.57 | novagroup.pl | |
| Advanticsp. z o.o. | $12,313,922.71 | advantic.com.pl | |
| MassmedicaS.A. | $8,216,274.00 | massmedica.com |
Change history
| Date | Event |
|---|---|
| 2014-06-30 | Address change (Postępu 6, 02-676, Warszawa → Hankiewicza 2, 02-103, Warszawa) |
| 2011-11-17 | PKD change (Removed: 51.18.Z, 51.46.Z, 74.87; Added: 46.18.Z, 46.19.Z, 46.46.Z, 46.75.Z, 74.90.Z, 77.40.Z) |
| 2009-01-20 | Address change (Hankiewicza 2, 02-103, Warszawa → Postępu 6, 02-676, Warszawa) |
| 2005-12-20 | Address change (Wilcza 31/1a, 00-544, Warszawa → Hankiewicza 2, 02-103, Warszawa) |
| 2005-08-03 | Entered in the register |
FAQ
Last updated: 2026-07-15